Publication | Closed Access

Effects of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction

CardiomyopathyHeart FailureCardiovascular DiseaseAtherosclerosisMedicinePhysiologyCardiovascular PharmacologyNormolipidemic RatsCardiomyocyte HypertrophyPharmacologyCardiologyMyocardial Infarction